Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).
Journal
Bone marrow transplantation
ISSN: 1476-5365
Titre abrégé: Bone Marrow Transplant
Pays: England
ID NLM: 8702459
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
22
10
2019
accepted:
04
03
2020
revised:
02
03
2020
pubmed:
24
3
2020
medline:
22
6
2021
entrez:
24
3
2020
Statut:
ppublish
Résumé
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative procedure in patients with Shwachman-Diamond syndrome (SDS) with bone marrow abnormalities. The results of 74 patients with SDS (6 acute myeloid leukemia, 7 myelodysplastic syndrome, and 61 bone marrow failure) treated with HSCT between 1988 and 2016 are reported. The donor source was: 24% sibling, 8% parent, and 68% unrelated donor. The stem cell source was: 70% bone marrow, 19% peripheral blood stem cells, and 11% cord blood. The conditioning regimen was myeloablative in 54% and reduced intensity in 46%. Neutrophil engraftment was achieved in 84% of patients after a median time of 17.5 days. Graft failure occurred in 15% of HSCTs. Grades I-IV acute and chronic GVHD were observed in 55% and 20% of patients, respectively. After a median follow-up of 7.3 years (95% CI 4.8-10.2), 28 patients died for progression/relapse (7) or toxicity (21). The 5-year overall survival and nonrelapse mortality were 63.3% (95% CI 50.8-73.4) and 19.8% (95% CI 10.8-30.8), respectively. In conclusion, this is the largest series so far reported and confirms that HSCT is a suitable option for patients with SDS. Further efforts are needed to lower transplant-related toxicity and reduce graft failure.
Identifiants
pubmed: 32203264
doi: 10.1038/s41409-020-0863-z
pii: 10.1038/s41409-020-0863-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1796-1809Commentaires et corrections
Type : ErratumIn
Références
Goobie S, Popovic M, Morrison J, Ellis L, Ginzberg H, Boocock GR, et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet. 2001;68:1048–54.
pubmed: 11254457
pmcid: 1275624
Boocock GR, Morrison JA, Popovic M, Richards N, Ellis N, Durie PR, et al. Mutations in SBDS are associated with Shwachman–Diamond syndrome. Nat Genet. 2003;33:97–101.
pubmed: 12496757
Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011;1242:40–55.
pubmed: 22191555
Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, et al. Haematopoietic stem cell transplantation for Shwachman– Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol. 2005;131:231–6.
pubmed: 16197455
Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B, et al. Hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transpl. 2005;36:787–92.
Isaev AA, Deev RV, Kuliev, Plaxa iL, Stancheva NV, Borovkova AS, et al. First experience of hematopoietic stem cell transplantation treatment of Shwachman–Diamond syndrome using unaffected HLA–matched sibling donor produced through preimplantation HLA typing. Bone Marrow Transpl. 2017;52:1249–52.
Barber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.
Carreras E, Dufour C, Mohty M, Kroger N. The EBMT Handbook. Hematopoietic stem cell transplantation and cellular therapy. Springer Open ebook 2019. https://doi.org/10.1007/978-3-030-02278-5 .
Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transpl. 2008;41(Suppl 2):S58–64. EBMT Paediatric Working Party.
Dignan FL, Amrolia P, Clark A, Comish J, Jackson G, Mahendra P, et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol. 2012;158:46–61.
pubmed: 22533811
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628–33.
pubmed: 19896087
pmcid: 19896087
Tsai PH, Sahdev I, Herry A, Lipton JM. Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman-Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol. 1990;12:472–6.
pubmed: 2285129
Barrios N, Kirkpatrick D, Regueira O, Wuttke B, McNeil J, Humbert J. Bone marrow transplant in Shwachman Diamond syndrome. Br J Haematol. 1999;79:337–8.
Seymour JF, Escudier SM. Acute leukemia complicating bone marrow hypoplasia in an adult with Shwachman’s syndrome. Leuk Lymphoma. 1993;12:131–5.
pubmed: 7512852
Smith OP, Chan MY, Evans J, Veys P. Shwachman-Diamond syndrome and matched unrelated donor BMT. Bone Marrow Transpl. 1995;16:717–8.
Smith OP, Hann IM, Chessells JM, Reeves BR, Milla P. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol. 1996;94:279–84.
pubmed: 8759887
Bunin N, Leahey A, Dunn S. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation. Transplantation. 1996;61:664–6.
pubmed: 8610401
Arseniev L, Diedrich H, Link H. Allogeneic bone marrow transplantation in a patient with Shwachman-Diamond syndrome. Ann Hematol. 1996;72:83–4.
pubmed: 8597612
Dokal I, Rule S, Chen F, Potter M, Goldman J. Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman-Diamond syndrome. Br J Haematol. 1997;99:171–3.
pubmed: 9359520
Davies SM, Wagner JE, DeFor T, Blazar BR, Katsanis E, Kersey JH, et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol. 1997;96:749–56.
pubmed: 9074418
Okcu F, Roberts WM, Chan KW. Bone marrow transplantation in Shwachman–Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant. 1998;21:849–51.
pubmed: 9603415
Miano M, Porta F, Locatelli F, Miniero R, La Nasa G, Di Bartolomeo P, et al. Unrelated donor marrow transplantation for inborn errors. Bone Marrow Transpl. 1998;21:S37–41.
Faber J, Lauener R, Wick F, Betts D, Filgueira L, Seger RA, et al. Shwachman-Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis. Eur J Pediatr. 1999;158:995–1000.
pubmed: 10592077
Cipolli M, D’Orazio C, Delmarco A, Marchesini C, Miano A, Mastella G. Shwachman’s syndrome: pathomorphosis and long-term outcome. J Pediatr Gastroenterol Nutr. 1999;29:265–72.
pubmed: 10467990
Cesaro S, Guariso G, Calore E, Gazzola MV, Destro R, Varotto S, et al. Successful unrelated bone marrow transplantation for Shwachman-Diamond syndrome. Bone Marrow Transpl. 2001;27:97–9.
Fleitz J, Rumelhart S, Goldman F, Ambruso D, Sokol RJ, Pacini D, et al. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome. Bone Marrow Transpl. 2002;29:75–9.
Hsu JW, Vogelsang G, Jones RJ, Brodsky RA. Bone marrow transplantation in Shwachman-Diamond syndrome. Bone Marrow Transpl. 2002;30:255–8.
Park SY, Chae MB, Kwack YG, Lee MH, Kim I, Kim YS, et al. Allogeneic bone marrow transplantation in Shwachman-Diamond syndrome with malignant myeloid transformation. A case report. Korean J Intern Med. 2002;17:204–6.
pubmed: 12298432
pmcid: 4531678
Cunningham J, Sales M, Pearce A, Howard J, Stallings R, Telford N, et al. Does isochromosome 7q mandate bone marrow transplant in children with Shwachman–Diamond syndrome? Br J Haematol. 2002;119:1062–9.
pubmed: 12472589
Mitsui T, Kawakami T, Sendo D, Katsuura M, Shimizu Y, Hayasaka K. Successful unrelated donor bone marrow transplantation for Shwachman-Diamond syndrome with leukemia. Int J Hematol. 2004;79:189–92.
pubmed: 15005350
Vibhakar R, Radhi M, Rumelhart S, Tatman T, Goldman F. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transpl. 2005;36:855–61.
Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K, et al. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman–Diamond syndrome. Bone Marrow Transpl. 2007;39:143–7.
Bhatla D, Davies SM, Shenoy S, Harris RE, Crockett M, Shoultz L, et al. Reduced intensity conditioning is safe and effective for transplantation of patients with Shwachman Diamond syndrome. Bone Marrow Transpl. 2008;42:159–65.
Linden T, Ehlert K, Niemeyer CM, Fleischhack G, Jürgens H, Rossig C. Molecular diagnosis of Shwachman-Diamond syndrome in a child with incomplete clinical disease phenotype. Pediatr Blood Cancer. 2010;55:177–9.
pubmed: 20486183
Bizzetto R, Bonfim C, Rocha V, Sociè G, Locatelli F, Chan K, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011;96:134–41.
pubmed: 21071499
Keogh SJ, McKee S, Smithson SF, Grier D, Steward CG. Shwachman-Diamond syndrome: a complex case demonstrating the potential for misdiagnosis as asphyxiating thoracic dystrophy (Jeune syndrome). BMC Pediatr. 2012;12:48.
pubmed: 22554078
pmcid: 3457858
Bertaina A, Merli P, Rutella S, Pagliara D, Bernardo ME, Masetti R, et al. HLA-haploidentical stem cell transplantation after removal of αβ+T and B cells in children with nonmalignant disorders. Blood. 2014;124:822–6.
pubmed: 24869942
Myers KC, Rose SR, Rutter MM, Meha PA, Khoury JC, Cole T, et al. Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome genemutations and Shwachman-Diamond syndrome. J Pediatr. 2013;162:1235–40.
pubmed: 23305959
pmcid: 5693331
Myers KC, Bolyard AA, Otto B, Wong TE, Jones AT, Harris RE, et al. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North-American Shwachman-Diamond syndrome registry. J Pediatr. 2014;164:866–70.
pubmed: 24388329
Delaporta P, Sofocleous C, Economou M, Makis A, Kostaridou S, Kattamis A. The Greek Registry of Shwachman-Diamond syndrome: molecular and clinical data. Pediatr Blood Cancer. 2017;64:1–4.
Burroughs LM, Shimamura A, Talano JA, Domm JA, Baker KK, Delaney C, et al. Allogeneic hematopoietic cell transplantation using treosulfan-based conditioning for treatment of marrow failure disorders. Biol Blood Marrow Transplant. 2017;23:1669–77.
pubmed: 28602958
pmcid: 5605451
Shimosato Y, Tanoshima R, Tsujimoto SI, Takeuchi M, Sakari K, Kajiwara R, et al. Association of isochromosome (7)(q10) in Shwachman-Diamond syndrome with the severity of cytopenia. Clin Case Rep. 2018;6:125–8.
pubmed: 29375851
Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahiaoui N, et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012;97:1312–9.
pubmed: 22491737
pmcid: 3436231
Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med. 2017;376:536–47.
pubmed: 5438571
pmcid: 5438571
Xia J, Miller CA, Baty J, Ramesh A, Jotte MRM, Fulton RS, et al. Somatic mutations and clonal hematopoiesis in congenital neutropenia. Blood. 2018;131:408–16.
pubmed: 29092827
pmcid: 5790127
Cremers EM, Van Biezen A, de Wreede LC, Scholten M, Vitek A, Finke J, et al. Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT. Ann Hematol. 2016;95:1971–8.
pubmed: 27650829
pmcid: 5093200
Bacigalupo A, Socie’ G, Lanino E, Prete A, Locatelli F, Cesaro S, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica. 2010;95:976–82.
pubmed: 20494932
pmcid: 2878797
Bardelli D, Dander E, Bugarin C, Cappuzzello C, Pievani A, Fazio G, et al. Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis. Br J Haematol. 2018;182:114–24.
pubmed: 29767474
Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transpl. 2019. https://doi.org/10.1038/s41409-019-0499-z .
doi: 10.1038/s41409-019-0499-z